Literature DB >> 12171949

Antagonist: endoscopic surveillance of patients with Barrett's oesophagus.

R J Playford1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12171949      PMCID： PMC1773347          DOI： 10.1136/gut.51.3.314

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  11 in total

1.  Barrett's esophagus: an overrated cancer risk factor.

Authors:  S J Spechler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.

Authors:  J W van Sandick; J J van Lanschot; B W Kuiken; G N Tytgat; G J Offerhaus; H Obertop
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

3.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.

Authors:  A van der Burgh; J Dees; W C Hop; M van Blankenstein
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

5.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia.

Authors:  T G Schnell; S J Sontag; G Chejfec; G Aranha; A Metz; S O'Connell; U J Seidel; A Sonnenberg
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

6.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

Authors:  N S Buttar; K K Wang; T J Sebo; D M Riehle; K K Krishnadath; L S Lutzke; M A Anderson; T M Petterson; L J Burgart
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

7.  Screening for oesophageal adenocarcinoma: an evaluation of a surveillance program for columnar metaplasia of the oesophagus.

Authors:  J Nilsson; V Skobe; J Johansson; R Willén; F Johnsson
Journal:  Scand J Gastroenterol       Date:  2000-01       Impact factor: 2.423

8.  Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study.

Authors:  C E Macdonald; A C Wicks; R J Playford
Journal:  BMJ       Date:  2000-11-18

9.  Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

Authors:  R E Rudolph; T L Vaughan; B E Storer; R C Haggitt; P S Rabinovitch; D S Levine; B J Reid
Journal:  Ann Intern Med       Date:  2000-04-18       Impact factor: 25.391

Review 10.  Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management.

Authors:  H J Stein; J R Siewert
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438
View more
  3 in total

1.  TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort.

Authors:  L Murray; A Sedo; M Scott; D McManus; J M Sloan; L J Hardie; D Forman; C P Wild
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

Review 2.  Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.

Authors:  Hugh Barr; Catherine Kendall; Florain Bazant-Hegemark; Paul Moayyedi; G Shetty; Nicholas Stone
Journal:  MedGenMed       Date:  2006-06-27

3.  Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.

Authors:  Fumiaki Sato; Zhe Jin; Karsten Schulmann; Jean Wang; Bruce D Greenwald; Tetsuo Ito; Takatsugu Kan; James P Hamilton; Jian Yang; Bogdan Paun; Stefan David; Alexandru Olaru; Yulan Cheng; Yuriko Mori; John M Abraham; Harris G Yfantis; Tsung-Teh Wu; Mary B Fredericksen; Kenneth K Wang; Marcia Canto; Yvonne Romero; Ziding Feng; Stephen J Meltzer
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.